134 related articles for article (PubMed ID: 36748214)
1. High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma
Lu Y; Li P; Zhou Y; Zhang J
Curr Cancer Drug Targets; 2023; 23(6):496-504. PubMed ID: 36748214
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
Sun QS; Luo M; Zhao HM; Sun H
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.
Zhu LB; Jiang J; Zhu XP; Wang TF; Chen XY; Luo QF; Shu Y; Liu ZL; Huang SH
Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775
[TBL] [Abstract][Full Text] [Related]
6. SRPK1 promotes cell proliferation and tumor growth of osteosarcoma through activation of the NF-κB signaling pathway.
Gong Y; Yang C; Wei Z; Liu J
Biol Chem; 2022 Jun; 403(7):653-663. PubMed ID: 34964567
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-κB signaling.
Hu X; Yang F; Mei H
J Orthop Sci; 2024 Jan; 29(1):306-314. PubMed ID: 36414514
[TBL] [Abstract][Full Text] [Related]
8. PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3.
Xuan ZH; Wang HP; Zhang XN; Chen ZX; Zhang HY; Gu MM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5259-5266. PubMed ID: 32495859
[TBL] [Abstract][Full Text] [Related]
9. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
10. Punicalagin suppresses osteosarcoma growth and metastasis by regulating NF-κB signaling.
Wang XZ; Zhang SF; Yang ZH; Ye ZW; Liu J
J Biol Regul Homeost Agents; 2020; 34(5):1699-1708. PubMed ID: 33148374
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of PKMYT1 is associated with autophagy inhibition and apoptosis induction and suppresses tumor progression in hepatocellular carcinoma.
Wu F; Tu C; Zhang K; Che H; Lin Q; Li Z; Zhou Q; Tang B; Yang Y; Chen M; Shao C
Biochem Biophys Res Commun; 2023 Jan; 640():173-182. PubMed ID: 36512849
[TBL] [Abstract][Full Text] [Related]
12. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP.
Wang Y; Huang H; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1458-1465. PubMed ID: 31007083
[TBL] [Abstract][Full Text] [Related]
13. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
14. Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a.
Chu Y; Fang Y; Chi J; Li J; Zhang D; Zou Y; Wang Z
Braz J Med Biol Res; 2018 Nov; 51(12):e7665. PubMed ID: 30462772
[TBL] [Abstract][Full Text] [Related]
15. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
16. PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity.
Wang S; Liu X; Zhou T; Li J; Lin Y; Zhou A; Huang J; Zhao J; Cai J; Cai X; Huang Y; Li X
Cell Oncol (Dordr); 2023 Feb; 46(1):195-209. PubMed ID: 36350496
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
18. Punicalagin inhibited proliferation, invasion and angiogenesis of osteosarcoma through suppression of NF‑κB signaling.
Huang T; Zhang X; Wang H
Mol Med Rep; 2020 Sep; 22(3):2386-2394. PubMed ID: 32705250
[TBL] [Abstract][Full Text] [Related]
19. The effects of TRAF6 on proliferation, apoptosis and invasion in osteosarcoma are regulated by miR-124.
Meng Q; Zhang W; Xu X; Li J; Mu H; Liu X; Qin L; Zhu X; Zheng M
Int J Mol Med; 2018 May; 41(5):2968-2976. PubMed ID: 29436576
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway.
Zhao J; Ma ST
Mol Med Rep; 2018 May; 17(5):7388-7394. PubMed ID: 29568924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]